share_log

This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst

Benzinga ·  11/17/2023 01:43

Needham initiated coverage on Dentsply Sirona Inc (NASDAQ:XRAY), citing its third turnaround effort since the 2016 Dentsply-Sirona merger. Under prior management, Dentsply Sirona improved its product portfolio but faced challenges in commercial execution. The current management prioritizes enhanced execution by investing in the commercial division, engaging customers, and streamlining portfolio efficiency. Needham analysts David Saxon, Mike Matson, and Joseph Conway note that the management's focus on improving commercial execution should allow it to capitalize on its competitive portfolio. XRAY believes it can reach 4-6% organic growth with ~500 bps of margin expansion by 2026, with potential upside driven by geographic expansion

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment